• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SHC1通过与表皮生长因子受体(EGFR)相互作用促进肺癌转移。

SHC1 Promotes Lung Cancer Metastasis by Interacting with EGFR.

作者信息

Yang Pan, Li Wei, Li Xiaoping

机构信息

Department of Thoracic Surgery, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin 300192, China.

出版信息

J Oncol. 2022 Jun 6;2022:3599832. doi: 10.1155/2022/3599832. eCollection 2022.

DOI:10.1155/2022/3599832
PMID:35706930
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9192283/
Abstract

The study aims to explore the biological function of SHC1 in the development and progression of lung cancer. Meanwhile, the effect of SHC1 and EGFR on lung cancer was analyzed. The expression of SHC1 in lung cancer and adjacent tissues was analyzed by bioinformatics and immunohistochemistry. Meanwhile, the relationship between SHC1 expression and prognosis was analyzed. SHC1 overexpression and knockdown cell lines were constructed by overexpression plasmid and knockdown plasmid. Cell proliferation was detected by CCK-8. Cell invasion was detected by transwell. Apoptosis was detected by TUNEL. Interaction between SHC1 and EGFR was detected. The expression of SHC1 in lung adenocarcinoma tissues was significantly higher than that in paracancer tissues. Lung cancer patients with high SHC1 expression have a poor prognosis. The proliferation and invasion of SHC1 decreased with SHC1 knockout but increased after overexpression. EGFR may be a key interaction protein of SHC1. Overexpression of EGFR increases the oncogenic effect of SHC1. In conclusion, SHC1 plays a carcinogenic role in lung cancer. EGFR expression was significantly correlated with SHC1 and maybe a key interaction protein of SHC1. SHC1 interacts with EGFR to form a protein complex, which may be a new target for lung cancer metastasis.

摘要

本研究旨在探讨SHC1在肺癌发生发展过程中的生物学功能。同时,分析SHC1和表皮生长因子受体(EGFR)对肺癌的影响。通过生物信息学和免疫组织化学分析SHC1在肺癌组织和癌旁组织中的表达情况。同时,分析SHC1表达与预后的关系。利用过表达质粒和敲低质粒构建SHC1过表达和敲低细胞系。采用CCK-8法检测细胞增殖情况。通过Transwell法检测细胞侵袭能力。采用TUNEL法检测细胞凋亡情况。检测SHC1与EGFR之间的相互作用。SHC1在肺腺癌组织中的表达明显高于癌旁组织。SHC1高表达的肺癌患者预后较差。敲除SHC1后其增殖和侵袭能力降低,而过表达后则增强。EGFR可能是SHC1的关键相互作用蛋白。EGFR的过表达增强了SHC1的致癌作用。综上所述,SHC1在肺癌中发挥致癌作用。EGFR表达与SHC1显著相关,可能是SHC1的关键相互作用蛋白。SHC1与EGFR相互作用形成蛋白复合物,这可能是肺癌转移的新靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/092a/9192283/98f2274f1009/JO2022-3599832.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/092a/9192283/d157c391af14/JO2022-3599832.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/092a/9192283/7c29cc27d178/JO2022-3599832.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/092a/9192283/e6276f8ddf32/JO2022-3599832.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/092a/9192283/5af8176d82bb/JO2022-3599832.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/092a/9192283/ffcf4125c12d/JO2022-3599832.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/092a/9192283/98f2274f1009/JO2022-3599832.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/092a/9192283/d157c391af14/JO2022-3599832.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/092a/9192283/7c29cc27d178/JO2022-3599832.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/092a/9192283/e6276f8ddf32/JO2022-3599832.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/092a/9192283/5af8176d82bb/JO2022-3599832.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/092a/9192283/ffcf4125c12d/JO2022-3599832.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/092a/9192283/98f2274f1009/JO2022-3599832.006.jpg

相似文献

1
SHC1 Promotes Lung Cancer Metastasis by Interacting with EGFR.SHC1通过与表皮生长因子受体(EGFR)相互作用促进肺癌转移。
J Oncol. 2022 Jun 6;2022:3599832. doi: 10.1155/2022/3599832. eCollection 2022.
2
CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer.CD151 通过 EGFR 信号促进非小细胞肺癌中整合素 α3β1 的肿瘤进展。
J Exp Clin Cancer Res. 2021 Jun 9;40(1):192. doi: 10.1186/s13046-021-01998-4.
3
The increased expression and aberrant methylation of SHC1 in non-small cell lung cancer: Integrative analysis of clinical and bioinformatics databases.SHC1 在非小细胞肺癌中的过度表达和异常甲基化:临床和生物信息学数据库的综合分析。
J Cell Mol Med. 2021 Jul;25(14):7039-7051. doi: 10.1111/jcmm.16717. Epub 2021 Jun 11.
4
PTPN6-EGFR Protein Complex: A Novel Target for Colon Cancer Metastasis.蛋白酪氨酸磷酸酶非受体型6-表皮生长因子受体蛋白复合物:结肠癌转移的新靶点
J Oncol. 2022 Feb 11;2022:7391069. doi: 10.1155/2022/7391069. eCollection 2022.
5
The E3 ubiquitin ligase NEDD4 mediates cell migration signaling of EGFR in lung cancer cells.E3 泛素连接酶 NEDD4 介导肺癌细胞中 EGFR 的细胞迁移信号转导。
Mol Cancer. 2018 Feb 19;17(1):24. doi: 10.1186/s12943-018-0784-2.
6
Overexpression of geranylgeranyl diphosphate synthase contributes to tumour metastasis and correlates with poor prognosis of lung adenocarcinoma.香叶基二磷酸合酶过表达促进肿瘤转移,并与肺腺癌不良预后相关。
J Cell Mol Med. 2018 Apr;22(4):2177-2189. doi: 10.1111/jcmm.13493. Epub 2018 Jan 29.
7
MicroRNA-130-5p promotes invasion as well as migration of lung adenocarcinoma cells by targeting the EZH2 signaling pathway.microRNA-130-5p 通过靶向 EZH2 信号通路促进肺腺癌细胞的侵袭和迁移。
Eur Rev Med Pharmacol Sci. 2019 Nov;23(21):9480-9488. doi: 10.26355/eurrev_201911_19442.
8
Enhanced expression of long non-coding RNA ZXF1 promoted the invasion and metastasis in lung adenocarcinoma.长链非编码RNA ZXF1的表达增强促进了肺腺癌的侵袭和转移。
Biomed Pharmacother. 2014 May;68(4):401-7. doi: 10.1016/j.biopha.2014.03.001. Epub 2014 Mar 19.
9
TRIM59 promotes gefitinib resistance in EGFR mutant lung adenocarcinoma cells.TRIM59 促进 EGFR 突变型肺腺癌细胞对吉非替尼的耐药性。
Life Sci. 2019 May 1;224:23-32. doi: 10.1016/j.lfs.2019.03.041. Epub 2019 Mar 19.
10
, a New Biomarker of Lung Adenocarcinoma.,一种肺腺癌的新型生物标志物。 (你提供的原文似乎不完整,开头缺少具体内容)
Front Oncol. 2021 Oct 20;11:754290. doi: 10.3389/fonc.2021.754290. eCollection 2021.

引用本文的文献

1
p66Shc deletion confers apoptotic resistance to loss of EGFR-ERK signalling in neural stem cells.p66Shc基因缺失赋予神经干细胞对表皮生长因子受体-细胞外信号调节激酶信号通路缺失的凋亡抗性。
Cell Death Dis. 2025 Jul 1;16(1):479. doi: 10.1038/s41419-025-07778-8.
2
Integrative analysis of exosomal ncRNAs and their regulatory networks in liver cancer progression.外泌体非编码RNA及其调控网络在肝癌进展中的综合分析
Pract Lab Med. 2025 Mar 21;45:e00464. doi: 10.1016/j.plabm.2025.e00464. eCollection 2025 Jul.
3
SHC1 serves as a prognostic and immunological biomarker in clear cell renal cell carcinoma: a comprehensive bioinformatics and experimental analysis.

本文引用的文献

1
Structure-based classification predicts drug response in EGFR-mutant NSCLC.基于结构的分类预测 EGFR 突变型 NSCLC 的药物反应。
Nature. 2021 Sep;597(7878):732-737. doi: 10.1038/s41586-021-03898-1. Epub 2021 Sep 15.
2
The Effect of Advances in Lung-Cancer Treatment on Population Mortality.肺癌治疗进展对人群死亡率的影响。
N Engl J Med. 2020 Aug 13;383(7):640-649. doi: 10.1056/NEJMoa1916623.
3
Cartilage Oligomeric Matrix Protein promotes epithelial-mesenchymal transition by interacting with Transgelin in Colorectal Cancer.
SHC1 作为透明细胞肾细胞癌的预后和免疫生物标志物:全面的生物信息学和实验分析。
Sci Rep. 2024 Aug 30;14(1):20150. doi: 10.1038/s41598-024-70897-3.
4
Prognostic and onco-immunological value of immune-related eRNAs-driven genes in lung adenocarcinoma.免疫相关 eRNAs 驱动基因在肺腺癌中的预后和肿瘤免疫价值。
J Cancer Res Clin Oncol. 2024 Apr 11;150(4):188. doi: 10.1007/s00432-024-05687-5.
5
Elaboration and validation of a prognostic signature associated with disulfidoptosis in lung adenocarcinoma, consolidated with integration of single-cell RNA sequencing and bulk RNA sequencing techniques.一项与肺腺癌中二硫键过氧化相关的预后标志物的构建和验证,结合单细胞 RNA 测序和批量 RNA 测序技术。
Front Immunol. 2023 Oct 27;14:1278496. doi: 10.3389/fimmu.2023.1278496. eCollection 2023.
6
Identification and Validation of Anoikis-Related Signatures for Predicting Prognosis in Lung Adenocarcinoma with Machine Learning.利用机器学习识别和验证与失巢凋亡相关的特征以预测肺腺癌预后
Int J Gen Med. 2023 May 16;16:1833-1844. doi: 10.2147/IJGM.S409006. eCollection 2023.
7
Establishment of a new prognostic risk model of MAPK pathway-related molecules in kidney renal clear cell carcinoma based on genomes and transcriptomes analysis.基于基因组和转录组分析建立肾透明细胞癌中MAPK信号通路相关分子的新预后风险模型
Front Oncol. 2023 Mar 10;13:1077309. doi: 10.3389/fonc.2023.1077309. eCollection 2023.
软骨寡聚基质蛋白通过与结直肠癌细胞中的 Transgelin 相互作用促进上皮-间充质转化。
Theranostics. 2020 Jul 9;10(19):8790-8806. doi: 10.7150/thno.44456. eCollection 2020.
4
Lung Cancer 2020: Epidemiology, Etiology, and Prevention.肺癌 2020:流行病学、病因学和预防。
Clin Chest Med. 2020 Mar;41(1):1-24. doi: 10.1016/j.ccm.2019.10.001.
5
Diurnal oscillations of endogenous HO sustained by p66 regulate circadian clocks.内源性 HO 的昼夜波动由 p66 调控的。
Nat Cell Biol. 2019 Dec;21(12):1553-1564. doi: 10.1038/s41556-019-0420-4. Epub 2019 Nov 25.
6
Drug resistance to targeted therapeutic strategies in non-small cell lung cancer.非小细胞肺癌中靶向治疗策略的耐药性。
Pharmacol Ther. 2020 Feb;206:107438. doi: 10.1016/j.pharmthera.2019.107438. Epub 2019 Nov 9.
7
Treatment of uncommon mutations in non-small cell lung cancer: new evidence and treatment.非小细胞肺癌罕见突变的治疗:新证据与治疗方法
Transl Lung Cancer Res. 2019 Jun;8(3):302-316. doi: 10.21037/tlcr.2019.04.12.
8
The p52 isoform of SHC1 is a key driver of breast cancer initiation.SHC1 的 p52 同种型是乳腺癌起始的关键驱动因素。
Breast Cancer Res. 2019 Jun 15;21(1):74. doi: 10.1186/s13058-019-1155-7.
9
Targeting exon 20 insertion mutations in non-small cell lung cancer.针对非小细胞肺癌中的外显子 20 插入突变。
Signal Transduct Target Ther. 2019 Mar 8;4:5. doi: 10.1038/s41392-019-0038-9. eCollection 2019.
10
Epidermal growth factor receptor T790M mutations in non-small cell lung cancer (NSCLC) of Yunnan in southwestern China.中国西南云南省非小细胞肺癌(NSCLC)中的表皮生长因子受体 T790M 突变。
Sci Rep. 2018 Oct 18;8(1):15426. doi: 10.1038/s41598-018-33816-x.